Simon M Y Lee Selected Research

Simon M Y Lee Research Topics

Disease

4	Neoplasms (Cancer) 10/2017 - 01/2012
3	Inflammation (Inflammations) 05/2023 - 01/2020
3	Cardiotoxicity 09/2018 - 10/2017
3	Parkinson Disease (Parkinson's Disease) 12/2015 - 01/2012
2	Pneumonia (Pneumonitis) 01/2024 - 05/2023
2	Atherosclerosis 01/2022 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2020 - 09/2018
2	Pheochromocytoma 02/2015 - 07/2012
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	COVID-19 10/2021
1	Neuroinflammatory Diseases 01/2018
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2017
1	Infarction (Infarctions) 11/2016
1	Cerebral Infarction 11/2016
1	Ischemic Stroke 11/2016
1	Stroke (Strokes) 11/2016
1	Osteoporosis 11/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Nerve Degeneration 01/2012
1	Ulcer 01/2012
1	Wounds and Injuries (Trauma) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 12/2007

Drug/Important Bio-Agent (IBA)

3	cucurbit(7)urilIBA 09/2018 - 10/2017
3	Artificial ReceptorsIBA 09/2018 - 10/2017
3	Proteins (Proteins, Gene)FDA Link 11/2016 - 07/2012
2	CyclodextrinsIBA 05/2023 - 01/2022
2	CurcuminIBA 05/2023 - 08/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 03/2017
2	AlginatesIBA 08/2017 - 03/2017
2	Neuroprotective AgentsIBA 11/2016 - 08/2012
2	Peptides (Polypeptides)IBA 02/2015 - 07/2012
1	AdamantaneIBA 05/2023
1	manganese dioxideIBA 05/2023
1	Liposomes (Liposome)IBA 01/2022
1	CholesterolIBA 01/2022
1	Liver X ReceptorsIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Antimalarials (Antimalarial Agents)IBA 10/2021
1	Chloroquine (Aralen)FDA LinkGeneric 10/2021
1	Clofazimine (Lamprene)FDA Link 12/2020
1	CytokinesIBA 01/2020
1	Antitubercular AgentsIBA 09/2018
1	bedaquiline (R207910)IBA 09/2018
1	Excipients (Suspending Agents)IBA 09/2018
1	cucurbit(8)urilIBA 01/2018
1	diphenyleneiodoniumIBA 01/2018
1	cucurbit(n)uril (cucurbituril)IBA 01/2018
1	Betulinic AcidIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	Schiff Bases (Schiff Base)IBA 08/2017
1	SolutionsIBA 08/2017
1	ProdrugsIBA 08/2017
1	Glutathione (Reduced Glutathione)IBA 03/2017
1	DisulfidesIBA 03/2017
1	sailuotongIBA 01/2017
1	Free RadicalsIBA 11/2016
1	VimentinIBA 11/2016
1	Therapeutic UsesIBA 11/2016
1	tetramethylpyrazineIBA 11/2016
1	tetramethylpyrazine nitroneIBA 11/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2015
1	VitaminsIBA 11/2015
1	Plant ExtractsIBA 08/2015
1	ProteomeIBA 02/2015
1	baicaleinIBA 08/2012
1	FlavonoidsIBA 08/2012
1	Semaxinib (SU5416)IBA 01/2012
1	Collagen Type I (Type I Collagen)IBA 01/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2012
1	AcetylcholinesteraseIBA 12/2007

Therapy/Procedure

6	Therapeutics 01/2024 - 01/2012
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2017
1	Intravenous Injections 01/2024
1	Hydrocolloid Bandages (Duoderm) 01/2012